Alyssa Wostrel


Advocacy is Alyssa Wostrel’s heartbeat as an influential and visionary non-profit professional with integrative health policy experience and education. Her experience as Executive Director of the Integrative Health Policy Consortium (IHPC) focused on healthcare reform and the advancement of pluralistic, interdisciplinary integrative healthcare. The 501(c)(4) non-profit was founded to represent the collective voice of integrative health care.

Her strengths are in developing and launching national inspiring, exciting, engaging integrative health educational programs rooted in policy initiatives and campaigns. Other significant experience includes coalition building, legislative advocacy, government relations, fundraising, successful grant applications, board development and governance, evolution of strategy, capacity building, and operational oversight.

Her corporate sector experience in pharmaceutical includes P+L responsibility for $5M+ budgets, sales team development, training and management, creative product marketing, and educational initiatives targeted toward practitioners.

Watch additional videos by this speaker

Additional Speakers

Moira Fitzpatrick, ND
Dr. Moira Fitzpatrick started her career in conventional psychology, and eventually she discovered Naturopathic Medicine and got her ND, and has built a career addressing mental health issues using an integrative approach.
Amy Rothenberg, ND
Dr. Rothenberg is a naturopathic physician in private practice, a writer, and a teacher of complimentary and alternative medicine.
Wendy Warner, MD, ABIHM
Dr. Wendy Warner is a nationally known lecturer and teacher, and a past president of the American Board of Integrative Holistic Medicine (ABIHM). She has been on the board of directors of ABIHM for a decade, and has helped the organization certify thousands of physicians in integrative holistic medicine.
Brad Jacobs, MD, MPH, ABIHM
Dr. Brad Jacobs leads executive health and corporate health programs whose clients include Google, PepsiCo, Gap Inc., Lilly Pharmaceuticals., Stanford Business School Beacon Program, and Harvard Business School Executive Education program.